マラリア診断の世界市場-2025年から2030年までの予測

マラリア診断市場は、CAGR 5.05%で、2025年の7億1,050万4,000米ドルから2030年には9億874万9,000米ドルに成長すると予測されます。

マラリア診断市場は、未治療の場合、重大な罹患率と死亡率を引き起こすこの病気を管理するために、早期かつ正確な診断が極めて重要であることから成長を遂げています。分子診断や迅速診断検査（RDT）を含む高品質の診断キットは、効果的な疾病管理に不可欠です。同市場は技術の進歩や政府資金の増加によって支えられているが、一部の地域では認知度の低さが課題となっています。本概要では、2023年以前の開発を除き、現在の動向、促進要因、抑制要因、主要参入企業に焦点を当てる。

市場促進要因

マラリア診断市場の主要促進要因は、診断技術、特にマラリアの迅速かつ正確な検出を可能にするRDTや分子診断の進歩です。これらの技術革新は、特に感染負荷の高い地域においてタイムリーな治療を可能にし、患者の予後を改善します。発展途上国におけるマラリア研究や啓発キャンペーンに対する政府資金の増加も、主要な成長要因の一つです。これらのイニシアチブは、診断へのアクセスを向上させ、特に流行地域における早期発見の重要性について地域社会を教育することを目的としています。マラリアによる世界の負担は、効率的な診断ツールの必要性を強調し続けており、市場の需要をさらに押し上げています。

市場抑制要因

マラリア診断市場は成長の可能性があるにもかかわらず、特定の地域、特にマラリアが流行している新興諸国では、人々の意識が低いという課題に直面しています。診断ツールやその利点に対する理解が乏しいため、導入が遅れ、効果的な疾病管理が妨げられる可能性があります。さらに、遠隔地ではヘルスケアのインフラが不十分であるなど、ロジスティクスの課題もあり、先進的診断へのアクセスが制限され、市場の拡大が制限される可能性があります。持続的な成長には、教育や流通網の改善を通じてこうした障壁に対処することが不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 市場スナップショット

• 市場概要
• 市場の定義
• 調査範囲
• 市場セグメンテーション

第3章 ビジネス情勢

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
• 産業バリューチェーン分析
• 施策と規制
• 戦略的提言

第4章 技術展望

第5章 マラリア診断市場：技術別

• イントロダクション
• 迅速診断検査（RDT）
• 顕微鏡検査
• 分子診断
• 血清学的検査
• その他

第6章 マラリア診断市場：エンドユーザー別

• イントロダクション
• 病院とクリニック
• 診断ラボ
• 研究機関
• NGOと政府の保健プログラム

第7章 マラリア診断市場：流通チャネル別

• イントロダクション
• 直接入札と施設販売
• 小売と民間

第8章 マラリア診断市場：地域別

• イントロダクション
• 北米
  • 技術別
  • エンドユーザー別
  • 流通チャネル別
  • 国別
    • 米国
    • カナダ
    • メキシコ
• 南米
  • 技術別
  • エンドユーザー別
  • 流通チャネル別
  • 国別
    • ブラジル
    • アルゼンチン
    • その他
• 欧州
  • 技術別
  • エンドユーザー別
  • 流通チャネル別
  • 国別
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • その他
• 中東・アフリカ
  • 技術別
  • エンドユーザー別
  • 流通チャネル別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • その他
• アジア太平洋
  • 技術別
  • エンドユーザー別
  • 流通チャネル別
  • 国別
    • 中国
    • 日本
    • 韓国
    • インド
    • インドネシア
    • タイ
    • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 市場シェア分析
• 合併、買収、合意とコラボレーション
• 競合ダッシュボード

第10章 企業プロファイル

• Motic（Xiamen）Electric Group Co., Ltd.
• Sight Diagnostics Ltd.
• bioMerieux SA
• Intellectual Ventures Laboratory, LLC
• Access Bio. Inc.
• Sysmex Europe GmbH
• Abbott Laboratories
• Meridian Bioscience, Inc.
• QuantuMDx Group Ltd.
• Hemex Health, Inc.
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Premier Medical Corporation Pvt. Ltd.

第11章 付録

• 通貨
• 前提条件
• 基準年と予測年のタイムライン
• 利害関係者にとっての主要メリット
• 調査手法
• 略語

The Global Malaria Diagnostics Market is expected to grow from USD 710.504 million in 2025 to USD 908.749 million in 2030, at a CAGR of 5.05%.

The malaria diagnostics market is experiencing growth driven by the critical need for early and accurate diagnosis to manage a disease that causes significant morbidity and mortality if untreated. High-quality diagnostic kits, including molecular diagnostics and rapid diagnostic tests (RDTs), are essential for effective disease management. The market is supported by technological advancements and increased government funding, though low awareness in some regions poses challenges. This summary focuses on current trends, drivers, restraints, and key players, excluding developments prior to 2023.

Market Drivers

The primary driver of the malaria diagnostics market is the advancement in diagnostic technologies, particularly RDTs and molecular diagnostics, which enable rapid and precise detection of malaria. These innovations improve patient outcomes by facilitating timely treatment, especially in high-burden regions. Increased government funding for malaria research and awareness campaigns in developing countries is another key growth factor. These initiatives aim to enhance access to diagnostics and educate communities about the importance of early detection, particularly in endemic areas. The global burden of malaria continues to underscore the need for efficient diagnostic tools, further propelling market demand.

Market Restraints

Despite its growth potential, the malaria diagnostics market faces challenges due to low awareness among populations in certain regions, particularly in developing countries where malaria is prevalent. Limited understanding of diagnostic tools and their benefits can delay adoption and hinder effective disease management. Additionally, logistical challenges, such as inadequate healthcare infrastructure in remote areas, may restrict access to advanced diagnostics, limiting market expansion. Addressing these barriers through education and improved distribution networks is essential for sustained growth.

Market Segmentation

By Diagnostic Type

The market is segmented into molecular diagnostics and RDTs, with RDTs dominating due to their ease of use, affordability, and suitability for point-of-care testing in resource-limited settings. Molecular diagnostics, while more precise, are gaining traction in advanced healthcare systems for their ability to detect low-level infections. Both segments are critical to addressing diverse diagnostic needs across global markets.

By Geography

The malaria diagnostics market is concentrated in high-burden regions, particularly Sub-Saharan Africa and parts of Asia, where malaria prevalence drives demand. Africa remains the largest market due to its significant disease burden and increasing government-led initiatives. The Asia-Pacific region is also growing, supported by rising investments in healthcare infrastructure and awareness programs. Developed regions like North America and Europe contribute through research and development of advanced diagnostic technologies.

Key Industry Players

Major players in the malaria diagnostics market include Motic (Xiamen) Electric Group Co., Ltd., Sight Diagnostics Ltd., bioMerieux SA, Intellectual Ventures Laboratory, LLC, Access Bio, Inc., Sysmex Europe GmbH, Abbott Laboratories, Meridian Bioscience, Inc., QuantuMDx Group Ltd., Hemex Health, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and Premier Medical Corporation Pvt. Ltd. These companies are driving innovation in diagnostic technologies and expanding access to testing solutions.

The malaria diagnostics market is poised for growth, driven by technological advancements and increased funding for malaria control. Low awareness and logistical challenges remain hurdles, particularly in endemic regions. With a focus on RDTs and molecular diagnostics, and strong growth in Africa and Asia-Pacific, the market is well-positioned to address global malaria challenges, provided stakeholders prioritize education and accessibility.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Malaria Diagnostics Market Segmentation:

By Technology

• Rapid Diagnostic Tests (RDTs)
• Microscopy
• Molecular Diagnostics
• Serology-based Tests
• Other Technologies

By End-Users

• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes
• NGOs and Government Health Programs

By Distribution Channel

• Direct Tenders & Institutional Sales
• Retail and Private

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY

• 5.1. Introduction
• 5.2. Rapid Diagnostic Tests (RDTs)
• 5.3. Microscopy
• 5.4. Molecular Diagnostics
• 5.5. Serology-based Tests
• 5.6. Other Technologies

6. MALARIA DIAGNOSTICS MARKET BY END-USERS

• 6.1. Introduction
• 6.2. Hospitals and Clinics
• 6.3. Diagnostic Laboratories
• 6.4. Research Institutes
• 6.5. NGOs and Government Health Programs

7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Direct Tenders & Institutional Sales
• 7.3. Retail and Private

8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Technology
  • 8.2.2. By End-Users
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Technology
  • 8.3.2. By End-Users
  • 8.3.3. By Distribution Channel
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Technology
  • 8.4.2. By End-Users
  • 8.4.3. By Distribution Channel
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Technology
  • 8.5.2. By End-Users
  • 8.5.3. By Distribution Channel
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Technology
  • 8.6.2. By End-Users
  • 8.6.3. By Distribution Channel
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. South Korea
    • 8.6.4.4. India
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Thailand
    • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Motic (Xiamen) Electric Group Co., Ltd.
• 10.2. Sight Diagnostics Ltd.
• 10.3. bioMerieux SA
• 10.4. Intellectual Ventures Laboratory, LLC
• 10.5. Access Bio. Inc.
• 10.6. Sysmex Europe GmbH
• 10.7. Abbott Laboratories
• 10.8. Meridian Bioscience, Inc.
• 10.9. QuantuMDx Group Ltd.
• 10.10. Hemex Health, Inc.
• 10.11. F. Hoffmann-La Roche Ltd.
• 10.12. Bio-Rad Laboratories, Inc.
• 10.13. Thermo Fisher Scientific Inc.
• 10.14. Premier Medical Corporation Pvt. Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations